The Pulmonary Rehabilitation Program at UC Davis Medical Center has been certified by the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) for leadership in improving health and quality of life for people with chronic obstructive pulmonary disease (COPD) and other lung diseases.
The comprehensive program involves individualized exercise and breathing therapies combined with education on smoking cessation, nutrition, sleep, medication and social activities. A major component of the program’s success is the community of support and networking it provides patients and their families.
“Lung disease can be very isolating, which only makes symptoms worse,” said Kimberly Hardin, director of pulmonary rehabilitation and professor of pulmonary, critical care and sleep medicine at UC Davis.
“We’ve created an atmosphere of acceptance and encouragement that motivates people to come together and make positive changes in their health,” Hardin added. “Our entire team of respiratory therapists, exercise physiologists, nutritionists, nurses, physicians and social workers is dedicated to helping patients make big improvements in their lung function — and their lives.”
The certification, which is valid for three years, requires an intensive evaluation for adherence to standards and guidelines developed and published by the AACVPR and other professional societies.
About the American Association of Cardiovascular and Pulmonary Rehabilitation
AACVPR is a multidisciplinary organization dedicated to reducing morbidity, mortality and disability from cardiovascular and pulmonary disease through education, prevention, rehabilitation, research and disease management. Central to the association’s core mission is improving quality of life for patients and their families. More information is at www.aacvpr.org
About pulmonary medicine at UC Davis
UC Davis is a national leader in compassionate, state-of-the-art care and research focused on improving treatment options for people with COPD, asthma, bronchiectasis, pulmonary fibrosis, cystic fibrosis and other lung diseases. Its ROAD (Reversible Obstructive Airway Disease) Program is a national model for reducing hospitalizations for people with COPD, and in 2015 U.S. News & World Report gave UC Davis its highest rating for COPD treatment. More information is at www.ucdmc.ucdavis.edu/internalmedicine/pulmonary/